Posted On: 01/21/2016 10:56:39 AM
Post# of 30079
Just my thoughts...
AVDX has a clean balance sheet and no toxic financers like AMBS has, this could be an advantage for investors/funds to invest sooner then if they would have had toxic financers.
Also their diagnostic tool for Ovarian Cancer (OvaDx) is far superior then what Roche has on the market right now and thats a 2 billion market!
I don't think Gregg will have much trouble getting investors to invest a couple of million with such a enormous market potential but thats just my uneducated guess lol.
Like Gregg said, Roche will probably buy OvaDx down the line or someone else will.
And that is assuming everything is based on truthfull facts, as how it was presented.
AVDX has a clean balance sheet and no toxic financers like AMBS has, this could be an advantage for investors/funds to invest sooner then if they would have had toxic financers.
Also their diagnostic tool for Ovarian Cancer (OvaDx) is far superior then what Roche has on the market right now and thats a 2 billion market!
I don't think Gregg will have much trouble getting investors to invest a couple of million with such a enormous market potential but thats just my uneducated guess lol.
Like Gregg said, Roche will probably buy OvaDx down the line or someone else will.
And that is assuming everything is based on truthfull facts, as how it was presented.
(0)
(0)
